News Daily News Balloon Predilation Not Mandatory Before TAVR, Meta-analysis Suggests Caitlin E. Cox April 21, 2017
News Daily News Early Clinical Outcomes With Evolut R Reassure, Suggest Improvements Over First-Gen CoreValve Michael O'Riordan February 09, 2017
News Daily News Clinical Outcomes With Subclavian TAVR as Good as With Transfemoral Access, Small Analysis Shows Michael O'Riordan January 26, 2017
News Daily News At 3 Years Post-TAVR, Valve Performance Holds Steady and Most Mortality Is Noncardiac: FRANCE 2 Registry Caitlin E. Cox October 04, 2016
News Daily News Sapien 3 Approved for Use in Intermediate-Risk Patients in Europe Michael O'Riordan September 20, 2016
News Daily News Survival Better, No ‘Risk Creep’ for TAVR vs Surgery in Lower-Risk Patients L.A. McKeown August 24, 2016
News Daily News FDA Approves Sapien XT and Sapien 3 for Intermediate-Risk Patients Yael L. Maxwell August 18, 2016
News Daily News Next-Generation CoreValve Device Receives CE Mark for Use in Intermediate-Risk Patients Todd Neale August 01, 2016
News Daily News Thrombus Relatively Common After LAA Occlusion With Amplatzer Amulet, Small Study Suggests Todd Neale July 28, 2016
News Daily News Equivalent Mortality at 30 Days and 1 Year With TAVR vs Surgery, Says Large Meta-analysis Michael O'Riordan June 07, 2016
News Daily News US and European Heart Failure Guidelines Advocate Use of Two New Therapies L.A. McKeown May 24, 2016
News Daily News Real-World Study Largely Confirms Effects of Apixaban, Rivaroxaban for A-fib Todd Neale April 21, 2016
News Daily News FDA Gives Greenlight for Low-Risk TAVR Study With CoreValve Michael O'Riordan February 21, 2016
News Daily News Study Hints That Many ICU Admissions for Acute MI Patients May Be Unnecessary Todd Neale September 28, 2015
News Daily News COURAGE Analysis: Patients With Lower Exercise Capacity No More Likely to Benefit from Revascularization L.A. McKeown September 09, 2015
News Daily News ADVANCE Published: Stroke Rate Diminishing as TAVR Evolves Yael L. Maxwell July 15, 2015
News Daily News Survival Benefit of CoreValve in High-Risk Patients Persists at 2 Years July 07, 2015
News Daily News Even With More Experience, Transapical TAVR Offers No Better QoL Than Surgery Caitlin E. Cox June 15, 2015